Statistics
Publications
20
Citations
1.3K
H-Index
16
Active since
2015
Ken Furudate is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and acute myeloid leukemia biology.
Publications per year
2015–2025
20
20
Outcomes of <i>TP53</i>‐mutant acute myeloid leukemia with decitabine and venetoclax
Kunhwa Kim, Abhishek Maiti, Sanam Loghavi et al. · Cancer · 2021 · 158 citations · Full text
Medicine, Hematology, Pharmacology +16
Lenalidomide promotes the development of <i>TP53</i>-mutated therapy-related myeloid neoplasms
Adam S. Sperling, Veronica Guerra, James A. Kennedy et al. · Blood · 2022 · 139 citations · Full text
Medicine, Hematology, Oncology +17
Kosei Kubota, Ryohei Ito, N Narita et al. · BMC Cancer · 2022 · 76 citations · Full text
Medicine, Immunology, Oncology +17
1–5 of 20